IN2013MU02528A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02528A
IN2013MU02528A IN2528MU2013A IN2013MU02528A IN 2013MU02528 A IN2013MU02528 A IN 2013MU02528A IN 2528MU2013 A IN2528MU2013 A IN 2528MU2013A IN 2013MU02528 A IN2013MU02528 A IN 2013MU02528A
Authority
IN
India
Prior art keywords
metopimazine
present
crystalline form
processes
pharmaceutical composition
Prior art date
Application number
Inventor
Mahadev Naik Anil
Dattatray Sawant Shreekant
Parshuram Pawar Milind
Sewak Mishra Shio
Original Assignee
Centaur Pharmaceuticals Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centaur Pharmaceuticals Private Ltd filed Critical Centaur Pharmaceuticals Private Ltd
Priority to IN2528MU2013 priority Critical patent/IN2013MU02528A/en
Publication of IN2013MU02528A publication Critical patent/IN2013MU02528A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a crystalline form B of Metopimazine. The present invention further relate to a processes of preparing crystalline form B of Metopimazine and pharmaceutical composition thereof.
IN2528MU2013 2013-07-31 2013-07-31 IN2013MU02528A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2528MU2013 IN2013MU02528A (en) 2013-07-31 2013-07-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2528MU2013 IN2013MU02528A (en) 2013-07-31 2013-07-31

Publications (1)

Publication Number Publication Date
IN2013MU02528A true IN2013MU02528A (en) 2015-06-26

Family

ID=54395885

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2528MU2013 IN2013MU02528A (en) 2013-07-31 2013-07-31

Country Status (1)

Country Link
IN (1) IN2013MU02528A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine
US11147820B2 (en) 2012-12-24 2021-10-19 Neurogastrx, Inc. Methods for treating GI tract disorders

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11147820B2 (en) 2012-12-24 2021-10-19 Neurogastrx, Inc. Methods for treating GI tract disorders
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine
WO2021202839A1 (en) * 2020-04-02 2021-10-07 Neurogastrx, Inc. Novel polymorphic forms of metopimazine
US11390620B2 (en) 2020-04-02 2022-07-19 Neurogastrx, Inc. Polymorphic forms of metopimazine
US11834445B2 (en) 2020-04-02 2023-12-05 Neurogastrx, Inc. Polymorphic forms of metopimazine
EP4126831A4 (en) * 2020-04-02 2024-04-17 Neurogastrx Inc Novel polymorphic forms of metopimazine

Similar Documents

Publication Publication Date Title
ZA201506682B (en) Compositions and methods for the improved production and delivery of rna
MX2020001756A (en) Benzoquinolone inhibitors of vmat2.
IN2013MU00646A (en)
MX345926B (en) Novel compositions, preparation thereof and use thereof for production of cast polyamides.
IN2013MU03641A (en)
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
IN2013MU03070A (en)
IN2013MU01111A (en)
MX2015016603A (en) Corticosteroid compositions.
IN2013MU01113A (en)
IL245260B (en) A crystalline anhydrous form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
MX2017001331A (en) Oral pharmaceutical composition of isotretinoin.
IN2013MU02528A (en)
IN2013MU04056A (en)
MX2015011881A (en) Process for the preparation of 3,7-dimethylnonan-1-ol.
MX2016006742A (en) Pharmaceutical composition.
MX2016002186A (en) Process for preparing dronedarone and salts thereof.
IN2013MU02715A (en)
IN2013MU03768A (en)
IN2013CH04330A (en)
IN2013CH05770A (en)
IN2013CH05769A (en)
IN2013CH05858A (en)
MX370849B (en) Improved process for the preparation of crystalline form iv of posaconazole.
IN2013CH05884A (en)